Key facts
- This page summarizes Crystal Sumner's Form 4 filing for Blend Labs, Inc. (BLND).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 26 Aug 2022, 16:04.
Crystal Sumner - 24 Aug 2022 Form 4 Insider Report for Blend Labs, Inc. (BLND)
- Reporting relationship
- Head of Legal, Compliance,Risk
- Issuer ticker
- BLND
- Reported as of
- 24 Aug 2022
- Net transaction value
- -$165,002
- SEC form
- 4
- Accepted by SEC
- 26 Aug 2022, 16:04:43 UTC
- Prior SEC filing
- 24 Aug 2022
- Next SEC filing
- 08 Sep 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Crystal Sumner
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Crystal Sumner filed Form 4 for Blend Labs, Inc. (BLND) on 26 Aug 2022.
Change
- Previous filing in this sequence was filed on 24 Aug 2022.
- Current net transaction value: -$165,002.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BLND
transaction
Class A Common Stock
Options Exercise
- Transaction value
- $6,977
- Shares
- +12,920
- Change %
- +2%
- Price
- $0.5400
- Shares after
- 647,403
- Date
- 24 Aug 2022
- Ownership
- Direct
- Footnotes
- F1
BLND
transaction
Class A Common Stock
Sale
- Transaction value
- $139,559
- Shares
- -47,631
- Change %
- -7.4%
- Price
- $2.93
- Shares after
- 599,772
- Date
- 24 Aug 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F3
BLND
transaction
Class A Common Stock
Options Exercise
- Transaction value
- $6,977
- Shares
- +12,920
- Change %
- +2.2%
- Price
- $0.5400
- Shares after
- 612,692
- Date
- 25 Aug 2022
- Ownership
- Direct
- Footnotes
- F1
BLND
transaction
Class A Common Stock
Sale
- Transaction value
- $39,397
- Shares
- -12,920
- Change %
- -2.1%
- Price
- $3.05
- Shares after
- 599,772
- Date
- 25 Aug 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BLND
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -12,920
- Change %
- -47%
- Price
- $0.000000
- Shares after
- 14,369
- Date
- 24 Aug 2022
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 12,920
- Exercise price
- $0.5400
- Footnotes
- F5
BLND
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -12,920
- Change %
- -90%
- Price
- $0.000000
- Shares after
- 1,449
- Date
- 25 Aug 2022
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 12,920
- Exercise price
- $0.5400
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Certain of these shares are represented by previously reported RSUs.
Footnote F2
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Footnote F3
This sale price represents the weighted average sale price of the shares sold ranging from $2.82 to $3.045 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Footnote F4
This sale price represents the weighted average sale price of the shares sold ranging from $2.98 to $3.12 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Footnote F5
The shares subject to this option are fully vested and immediately exercisable.